Purpose
To investigate the impact of supplementation with a targeted micronutrient formulation on the visual discomfort associated with vitreous degeneration.
Methods
In this clinical trial, 61 patients with symptomatic vitreous floaters were randomized to consume daily, the active supplement consisting of 125 mg
L
-lysine, 40 mg vitamin C, 26.3 mg
Vitis vinifera
extract, 5 mg zinc, and 100 mg
Citrus aurantium
or placebo for 6 months. Change in visual discomfort from floaters, assessed with the Floater Disturbance Questionnaire, was the primary outcome measure. Secondary outcome measures included best-corrected visual acuity, letter contrast sensitivity, photopic functional contrast sensitivity with positive and negative contrast polarity, and quantitative vitreous opacity areas.
Results
After supplementation, the active group reported a significant decrease in their visual discomfort from floaters (
P
< 0.001), whereas the placebo group had no significant change in their visual discomfort (
P
= 0.416). At 6 months, there was a significant decrease in vitreous opacity areas in the active group (
P
< 0.001) and an insignificant increase in vitreous opacity areas in the placebo group (
P
= 0.081). Also, there was a significant improvement in photopic functional contrast sensitivity with positive contrast polarity in the active group after supplementation (
P
= 0.047).
Conclusions
The findings of this study indicate improvements in vision-related quality of life and visual function of patients suffering from vitreous floaters after supplementation with a formulation of antioxidative and antiglycation micronutrients. Notably, these improvements were confirmed by the decrease in vitreous opacity areas in the active group.
Translational Relevance
This targeted dietary intervention should be considered to support patients with symptomatic vitreous degeneration.